Encompass Health Co. (NYSE:EHC) Shares Bought by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc lifted its stake in shares of Encompass Health Co. (NYSE:EHC) by 51.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 75,174 shares of the company’s stock after purchasing an additional 25,503 shares during the quarter. Ensign Peak Advisors Inc owned about 0.07% of Encompass Health worth $6,942,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of EHC. Tidal Investments LLC raised its position in Encompass Health by 5.7% in the third quarter. Tidal Investments LLC now owns 3,509 shares of the company’s stock worth $339,000 after acquiring an additional 188 shares in the last quarter. Miracle Mile Advisors LLC grew its stake in Encompass Health by 3.0% during the 4th quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company’s stock valued at $354,000 after acquiring an additional 112 shares in the last quarter. Pallas Capital Advisors LLC bought a new stake in shares of Encompass Health in the 4th quarter valued at approximately $237,000. Oak Thistle LLC bought a new stake in shares of Encompass Health in the 4th quarter valued at approximately $2,099,000. Finally, Park Avenue Securities LLC grew its stake in shares of Encompass Health by 44.7% in the 4th quarter. Park Avenue Securities LLC now owns 6,737 shares of the company’s stock valued at $622,000 after buying an additional 2,082 shares in the last quarter. 97.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. KeyCorp upped their target price on Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, April 25th. StockNews.com upgraded Encompass Health from a “hold” rating to a “buy” rating in a research note on Sunday. Truist Financial restated a “buy” rating and issued a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Royal Bank of Canada increased their price objective on Encompass Health from $110.00 to $125.00 and gave the stock an “outperform” rating in a research note on Monday, April 28th. Finally, William Blair reiterated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Encompass Health presently has an average rating of “Buy” and a consensus price target of $120.86.

Insider Activity

In related news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This trade represents a 6.79% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the business’s stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now directly owns 11,958 shares in the company, valued at $1,394,422.38. This trade represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 19,321 shares of company stock worth $2,142,452 in the last 90 days. Corporate insiders own 2.00% of the company’s stock.

Encompass Health Price Performance

Encompass Health stock opened at $117.89 on Wednesday. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The stock has a market cap of $11.88 billion, a price-to-earnings ratio of 26.43, a P/E/G ratio of 2.31 and a beta of 0.91. The business’s 50-day simple moving average is $104.14 and its 200 day simple moving average is $100.28. Encompass Health Co. has a 12-month low of $82.74 and a 12-month high of $118.27.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. During the same period in the previous year, the firm posted $1.12 earnings per share. Encompass Health’s revenue for the quarter was up 10.6% compared to the same quarter last year. As a group, research analysts anticipate that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.58%. The ex-dividend date is Tuesday, July 1st. Encompass Health’s dividend payout ratio (DPR) is currently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.